Company / Tangible Book Value per Share
Mirum Pharmaceuticals, Inc. Tangible Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$6.51
FY2025
5-year range
$4.83 / $6.73
FY2021-FY2025
Trend
+34.8%
vs FY2024
Sector context
#83 of 209
Health Care
What the data says
At $6.51, Mirum Pharmaceuticals, Inc.'s tangible book value per share ranks #83 of 209 in the Health Care sector. Tangible Book Value per Share has fluctuated over the past 8 years, ranging from $-19.25 in FY2018 to $11.35 in FY2019.
Based on SEC 10-K filings.
6.51 in FY2025 with a 5-year CAGR of -0.9%.
Declined from $6.73 to $6.51 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +5.0%
- 5-Year CAGR
- -0.9%
- 10-Year CAGR
- -
Sector benchmark
-94.6% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 34.8% year-over-year.
- Ranks #83 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2019.
- Lowest tangible book value per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.51 | +34.8% |
| FY2024 | $4.83 | -28.2% |
| FY2023 | $6.73 | +19.6% |
| FY2022 | $5.63 | -2.6% |
| FY2021 | $5.78 | -15.2% |
| FY2020 | $6.82 | -39.9% |
| FY2019 | $11.35 | +158.9% |
| FY2018 | -$19.25 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026